Schizophrenia is a complex disorder affecting approximately 1% of the population. 1) Classical neuroleptics, such as haloperidol ( Fig. 1) , are currently used for the treatment of this disease, but their use is associated with severe mechanism-related side effects, including induction of acute extrapyramidal symptoms (EPS).
2) Several aminoketones also possess potent antipsychotic (neuroleptic) activity: molindone, 3) first marketed in the U.S.A. in l974, has been used in the treatment of schizophrenia and psychosis, but its associated incidence of EPS is significant; the pyrrolo[2,3-g]isoquinoline piquindone (Ro 22-13l9) 4) is an antipsychotic with a low propensity to induce EPS. The clinical efficacy of classical antipsychotics in the treatment of schizophrenia and other psychotic disorders is directly related to their ability to block dopamine D 2 receptors in the brain; [5] [6] [7] however, it has been reported that dopamine receptor blockade in the striatum is closely associated with their extrapyramidal side effects. [8] [9] [10] Furthermore, the classical antipsychotics are ineffective against negative symptoms of schizophrenia such as apathy, motor retardation, flat affectivity and poverty of speech.
The introduction of clozapine for treatment-resistant schizophrenia gave rise to a new group of atypical or nonclassical antipsychotics which have no EPS and are effective against negative symptoms.
11-13) Clozapine blocks not only dopamine receptors but also 5-HT 2A serotonin receptors, and its atypical activity may be due to this latter feature; this focused attention on the interaction between the serotonin and dopamine systems as an avenue for superior therapeutics in schizophrenia, and demonstrated the implication of the serotoninergic system in this pathology. [14] [15] [16] Meltzer et al. 17, 18) suggested that in the efficacy of clozapine and other atypical antipsychotics as risperidone, olanzapine and quetiapine (Chart 1), 19) the most important factor is their relative affinities for D 2 and 5-HT 2A receptors. 20) Clozapine and other atypical antipsychotics have a pK i (5-HT 2A /D 2 ) ratio Ͼ1.12, whereas for typical antipsychotics this ratio is Ͻ1.09.
Current works based on experimental and clinical studies seem to confirm the major role of the 5-HT 2A receptor for the atypical profile of the antipsychotics. [21] [22] [23] [24] In fact, MDL 100907 ( Fig. 2) , a 5-HT 2A receptor selective antagonist, is being developed as a new atypical antipsychotic drug on the bases of data obtained in a wide-range of neurochemical, electrophysiological and behavioural models. [25] [26] [27] The study of the serotonin-dopamine interaction from a basic and clinical viewpoint promises a certain and substantial change in the pharmacotherapy of schizophrenia. The 5-HT 2A /D 2 concept has contributed to the development of com-pounds such as cinuperone, risperidone, 28) ocaperidone, 29) sertindole, 30) which are mixed 5-HT 2A /D 2 antagonists. Nevertheless, clozapine remains the prototype of atypical antipsychotic drugs and no currently available agents appear to have the spectrum of efficacy of clozapine. However, treatment with clozapine is associated with an increased risk of agranulocytosis, 31) which strongly limits its therapeutic use. Therefore, the discovery of a more effective side effects free therapy for the treatment of schizophrenia remains a challenging research goal.
As part of a program aimed at developing dopamine D 2 receptors, we have reported in previous papers [32] [33] [34] [35] the synthesis and atypical antipsychotic activity of 3-aminomethyl tetralones and 2-aminoethyl benzocycloalkanones which are conformationally restricted butyrophenone analogues of haloperidol with the aminobutyl side chain partially incorporated in a semirigid framework. As a continuation, we wish to report here on convenient methodologies for the preparation of 5-aminoethyl-and 6-aminomethyl-4,5,6,7-tetrahydroindol-4-ones (12a-e and 26a-f ) as cyclic butyrophenone derivatives in the indole series (Fig. 3) , as well as the results of studies of the affinities of the most active compounds for D 2 and 5-HT 2A receptors. Some preliminary results from this work have been published in communication form. 36, 37) Some of these compounds have two butyrophenone pharmacophores: the semirigid aminoalkyl indolone moiety and the 4-(p -fluorobenzoyl)piperidine fragment. The 4-(p-fluorobenzoyl)piperidine fragment may be considered as a butyrophenone pharmacophore constrained in a six membered ring; this fragment is also an important feature for 5-HT 2A binding. Moreover, the bioisosteric relationships between benzoyl and 1,2-benzisoxazol moieties are noteworthy. 38) In Charts 1, 2 and 3 are outlined the synthesis of 5-aminomethylindolones 12a-e. Knorr condensation of 2-isonitroso-3-pentanone with 1,3-cyclohexadione in 70% acetic acid afforded the 3-ethyl-2-methyl-1H-4,5,6,7-tetrahydroindol-4-one 1 with 60% yield. The conjugation between the pyrrole nitrogen and the carbonyl group deactivates both functions. Furthermore, the methylene group adjacent to this carbonyl group does not participate in base catalyzed condensations. However, if the nitrogen is substituted with a strong electron-withdrawing group such as benzenesulfonyl, the pyrrole ring is deactivated and consequently the carbonyl group activated by inhibiting electron release to it. The 1-benzenesulfonyl derivative 2 was readily prepared and could be alkylated with ethyl bromoacetate to afford the ester 3 according to our previously reported procedure. 39) Alternatively, the general strategy of malonic synthesis allowed the acid 4 to be obtained with overall yields of 40%. The benzenesulfonyl group so deactivates the pyrrole ring that bromination in the 5 position is favoured. Thus, treatment of 2 with cupric bromide afforded the 5-bromo ketone 5 in high yields (80%). The bromoderivative 5 was allowed to react with diethyl malonate in NaH/dimethylformamide (DMF) to give the ketodiester 6 (70%). One step cleavage of both ester and benzenesulfonyl groups with ethanolic sodium hydroxide afforded in very high yields (85%) the N-unprotected diacid 7, which was decarboxylated in the presence of cupric oxide to give the required monoacid 4 in quantitative yield.
The protected amides 9a-d were prepared as white crystalline solids in 65-85% yield by reaction of ketoester 3 with the appropriate dimethylaluminum amide (prepared in situ from a solution 2 M of trimethyl aluminum in hexane) followed by hydrolysis of the resulting complex (route A, Chart 2). Alternatively (route B, Chart 2), from the N-unprotected acid 4 by acid amine coupling with carboxylate activation by dicyclohexylcarbodiimide (DCC) in the presence of 1-hydroxybenzotriazole (HOBt) in DMF afforded the amides 8a-d in 55-80% yields. In order to avoid the formation of intractable tars and salts during the reduction due to the acidic NH group, it was protected as benzenesulfonyl derivative by reaction with benzenesulfonyl chloride in the presence of sodium hydride. Reduction of the ketonic group in 4-oxotetrahydroindoles with lithium aluminum hydride (LAH) or NaBH 4 has been reported to afford the methylene group. 40) However, we successfully reduced the N-protected amides 9a-d with AlH 3 in tetrahydrofuran (THF) to give the aminoalcohols 10a-d in quantitative yields which were oxidised to aminoketones 11a-d with pyridinium dichromate in 50-60% overall yield. Finally, the synthesis of the target compounds 12a-d was accomplished by removing the benzenesulfonyl protecting group with a) ethanolic sodium hydroxide (58-74%), or b) with the recently described 41) tetrabutyl ammonium fluoride (TBAF) in refluxing THF (70-75%).
In order to prepare the target compound 12e, the presence of two carbonyl groups is troublesome following the above procedure. Amide 9e was obtained similarly to the rest of amides described in this work. Reduction of ketoamide 9e 622 Vol. 47, No. 5 with boro or aluminum hydrides took place with secondary reactions to give by-products. The crude alcohol underwent oxidation slowly, and only amorphous solid was obtained.
According to these results, we explored another strategy which involved the protection of both ketonic groups. The synthesis was carried out from the ketoacid 4 with an overall yield of 7% as outlined in Chart 3. Most attempts to convert 9e into the corresponding ethylene ketal left the ketoamide unaffected. Ketalyzation of both carbonyl groups with ethylene glycol and pyridinium tosylate in anhydrous toluene with azeotropic distillation of water in a Dean-Stark apparatus proceeded very slowly and partially to afford bis ethylene ketal 13 in moderate yields (50%); it was isolated as a yellow foam which partially decomposes after attempted purification by column chromatography. The severe conditions which were necessary for ketal formation of 9e are probably a consequence of the increased steric hindrance. A number of attempts were made to reduce the carbonyl amide group of 13 to the corresponding amine. According to the reductive agent and reaction conditions, the results were as follows: a) LAH in Refluxing THF: Under these vigorous conditions, the reaction proceeds with cleavage of the benzenesulfonyl protecting group (related reductions of benzenesulfonyl groups have been reported 42) ) as well as reductive cleavage of the indolone ketal and reduction of the amide carbonyl group. The more stable ketal of benzoyl carbonyl group remain unaffected. After chromatographic purification, compound 16 was obtained as a foam and characterized by spectroscopic data. b) LAH in Refluxing Diethyl Ether: In these conditions only reduction of the amide group took place. The resulting crude foam which also partially decomposes after attempted chromatographic purification, was allowed to react with HCl-MeOH to cleavage both ketals. Protected aminoketone 15 was obtained (55%) as a yellow oil which was identified by the usual spectroscopic measurements. Despite the facile removing of the benzenesulfonyl group in the previous examples, it was difficult to remove it in this compound either in strong alkaline conditions or by reduction (magnesium in MeOH). However, reductive cleavage with sodium in ammonia was successful. In these mild conditions, amine 12e was obtained in 50-60% yield. c) Aluminum Hydride in THF: The reaction proceeds with reductive cleavage of the indolone ketal and reduction of the amide carbonyl group. The benzoyl and benzenesulfonyl groups remain unaffected. Acidic hydrolysis of the resulting crude foam 17 give the protected pyrrol ketone 18 (14% Chart 1 Chart 2 from 13) isolated as a crystalline oxalate.
For the synthesis of 6-aminomethyl indolones 26a-f, several retrosynthetic strategies (Chart 4) are possible by using the pyrrole ring previously formed (A and B) or generating it at the last steps of the procedure (C). In route A, WilsmeirHaak formylation of 2-methyl-3-ethylpyrrol and Stobbe condensation are the key steps. Alternatively (route B), succinoylation, aminomethylation and ring closure would lead to the desired compounds. In cases A and B, the procedures have a high number of steps and according to our experience in the benzene and thiophene series, 32, 43) the final ring closure would likely proceed with only moderate yields. In route C, the key step is a Knorr pyrrole formation upon the 5-hydroxymethyl-1,3-cyclohexanedione. Accordingly, we considered and successfully explored case C, where the number of steps is lower, the reactions, surprisingly for pyrrole chemistry, are clean and overall yields are good.
In Chart 5 is shown the procedure followed for preparation of final compounds 26a-f with overall yields from 15% to 25%. Birch reduction of 3,5-dimethoxybenzoic acid with lithium-ammonia in methanol afforded 1,4-dihydro-3,5-dimethoxybenzoic acid 21. 44) Treatment of this compound with LAH in THF gave the hydroxymethyl alcohol 22 45) in 85% yield over two steps. Pyrrole ring formation was achieved by Knorr methodology with 2-isonitroso-3-pentanone refluxing in 70% acetic acid in the presence of zinc powder to yield a mixture of 3-ethyl-2-methyl-6-acetoxymethyl-4,5,6,7-tetrahydroindol-4-one 23 (30%) and 3-ethyl-2-methyl-6-hydroxymethyl-4,5,6,7-tetrahydroindol-4-one 24 (30%). After chromatographic separation, the acetyl ester 23 on treatment with 10% ethanolic potassium hydroxide gave 24 (60%) as a white crystalline solid. Reaction of the alcohol 24 with p-toluenesulfonyl chloride in pyridine afforded the tosylate 25 (75%), which underwent subsequent nucleophilic displacement with heterocyclic amines in Nmethyl-2-pyrrolidone, providing the amines 26a-f as white crystalline solids with yields ranging 40-75% (Table 1) . Linear butyrophenone 26g was prepared from the corresponding piperazine-free derivative 26b with a yield of 51%, by alkylation of the piperazine-free nitrogen with 4-chloro-1,1-ethylenedioxy-1-(4-fluorophenyl)butane in methyl isobutyl ketone after addition of catalytic amounts of potassium iodide as previously reported by us, 34) followed by acidic hydrolysis of the resulting ethylene ketal. Replacement of the benzoyl group of 26e by its bioisoster, the 1,2-benzisoxazol-3-yl group, to give 26f, significantly increases the affinity at both D 2 and 5-HT 2A receptors. The pK i 5-HT 2A /D 2 for this compound is 1.17, similar to that of the atypical antipsychotic clozapine.
In conclusion, we have developed a practical and efficient synthetic approach for obtaining butyrophenone derivatives in the indole series as atypical antipsychotics. Modification of the amine substituent of molindone and the increase of the b-aminoketone chain to give a butyrophenone structure have given compounds with high affinities for the serotonin 5-HT 2A and the dopamine D 2 receptors. The promising affinity for both D 2 and 5-HT 2A receptors showed by compounds 26e (QF 0408B) and 26f (QF 0409B) together with their high Meltzer's ratio has prompted us to choose these compounds for further development.
Experimental
Chemistry Melting points were determined with a Kofler's hot stage instrument or a Gallenkamp capillary melting point apparatus and are uncorrected. Infrared spectra were recorded with a Perkin Elmer 1600 FTIR spectrophotometer; main bands are given in cm
Ϫ1
. Proton NMR spectra ( 1 H-NMR) and 13 C-NMR spectra were recorded with a Bruker WM AMX (300 MHz). Chemical shifts are recorded in parts per million (d) downfield from tetramethylsilane (TMS). Mass spectra were performed on a Kratos MS-50 or Varian Mat-711 mass spectrometer in a fast atom bombardment (FAB) mode (2-hydroxyethyl disulphide as a matrix) or by electronic impact (EI). Silica gel used for flash column chromatography was Kieselgel 60 (60-200 mesh) (E. Merck AG, Darmstadt, Germany). The progress of reaction was monitored by thin layer chromatography (TLC) on Merck 60 GF 254 chromatogram sheets and the purified compounds each showed a single spot; unless otherwise stated iodine vapour and/or UV light were used for detection.
Elemental combustion analyses were performed on a Perkin Elmer 240B apparatus at the Microanalyses Service of our University; unless otherwise stated all reported values were within Ϯ0.4% of theoretical compositions. The solvents used were purified by distillation over a drying agent under argon atmosphere and used immediately. The following drying agents were used: Na/benzophenone for THF, ether, toluene; P 2 O 5 for CH 2 Cl 2 ; K 2 CO 3 for acetone and ethyl acetate; KOH for pyridine and triethylamine; CaSO 4 1-Benzenesulfonyl-3-ethyl-2-methyl-4,5,6,7-tetrahydroindol-4-one (2) To a suspension of 55% NaH (3.7 g, 0.084 mol) in dry DMF (50 ml), a solution of ketone 1 (15.0 g, 0.084 mol) in dry DMF (50 ml) was added dropwise. The mixture was stirred at room temperature for 1 h, and then benzenesulfonyl chloride (10.7 ml, 0.084 mol) was added. The mixture was stirred at 65°C for 12 h. The solvent was removed in vacuo and the residue was dissolved in CH 2 Cl 2 , washed with water and brine, dried (Na 2 SO 4 ), filtered and concentrated at reduced pressure to give an oil which was purified by flash chromatography (AcOEt/ Ethyl 1-Benzenesulfonyl-3-ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylacetate (3) To a stirred mixture of diisopropylamine (2.98 ml, 0.021 mol) in dry THF (200 ml) at Ϫ20°C, a 2.5 M solution of n-BuLi in hexane (8.53 ml, 0.021 mol) was added. The mixture was stirred for 30 min a t Ϫ20°C and a further 30 min at Ϫ70°C. After this time, a solution of ketone 2 (6.65 g, 0.021 mol) in dry THF (60 ml) was added dropwise. After stirring 1 h at Ϫ70°C, ethyl bromoacetate (2.0 ml, 0.021 mol) was added, and the mixture was stirred for 30 min at Ϫ70°C and then 18 h at room temperature. The solvent was removed in vacuo and the residue was dissolved in AcOEt, washed with water, 5% NaHCO 3 and 5% HCl. The organic extracts were dried (Na 2 SO 4 ) and concentrated to give a residue which was purified by column chromatography (CH 2 Cl 2 ) to yield 7.5 g (45%) of 3 as a pale yellow oil. IR (film) cm 3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylacetic acid (4) To a solution of ester 3 (2.25 g, 5.5 mmol) in methanol (6 ml), a 15% solution of NaOH in methanol (4.4 ml, 16.5 mmol) was added. The mixture was stirred at reflux temperature for 2 h. After this time, the solvent was removed under reduced pressure; the residue was dissolved in water, washed with CH 2 Cl 2 and acidified with conc. HCl. The solid precipitate was collected by filtration and crystallized from methanol to give 0.95 g (75%) of the acid 4, mp 231-232°C (MeOH Diethyl 1-Benzenesulfonyl-3-ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolyl-malonate (6) To a stirred suspension of 50% NaH (0.19 g, 7.72 mmol) in anhydrous benzene (15 ml) and DMF (5 ml) at 0-5°C, a solution of diethyl malonate (0.67 g, 4.16 mmol) in benzene (5 ml) was added dropwise. After 15 min, a solution of compound 5 (1.50 g, 3.79 mmol) in benzene (5 ml) and DMF (1 ml) was added, and then, the mixture was stirred at 90°C for 3 h. After cooling, water (50 ml) was added; the aqueous phase was extracted with AcOEt and the combined organic extracts were dried and concentrated under reduced pressure. 
3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylmalonic acid (7)
A 15% solution of NaOH in ethanol (3.6 ml, 13.5 mmol, 4 eq) was added to a solution of diester 6 (1.6 g, 3.4 mmol) in ethanol (25 ml). The mixture was stirred at 80°C for 20 h. After this time, the solid was collected by filtration, dissolved in water, acidified with 6 N HCl and extracted with AcOEt. The organic phase was dried (Na 2 3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylacetic acid (4) Copper(I) oxide (0.38 g, 2.6 mmol) was added to a solution of diacid 7 (2.20 g, 7.9 mmol) in dry acetonitrile (50 ml), and the mixture was stirred at reflux temperature for 20 h. After this time, the solvent was removed in vacuo, the residue was dissolved in 0.5% NaOH, filtered and acidified with 6 N HCl to pH 4. The solid precipitate was collected by filtration to give 1.76 g (95%) of a yellow solid, identical to the previously described acid 4.
N-(3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylacetyl)morpholine (8a) General procedure A solution of morpholine (0.36 ml, 5.9 mmol), 1-hydroxybenzotriazole (1.61 g, 11.9 mmol) and the acid 4 (1.40 g, 5.9 mmol) in DMF (15 ml) was stirred at room temperature for 15 min. Then, the mixture was cooled to 0°C and dicyclohexylcarbodiimide (2.45 g, 11.9 mmol) was added. After stirring for 20 h at room temperature, the precipitate was filtered off and the filtrate was diluted with AcOEt and washed with 5% NaHCO 3 . The organic layer was dried (Na 2 SO 4 ) and evaporated; the residue was purified by column chromatography (AcOEt) to give 1.45 g (80%) of the amide 8a, mp 165-166°C (AcOEt 3 mmol) in dry DMF (10 ml) was added dropwise. The mixture was stirred at room temperature for 1 h, and then benzenesulfonyl chloride (0.41 ml, 3.3 mmol) was added. The mixture was stirred at 65°C for 12 h. The solvent was removed in vacuo and the residue was dissolved in CH 2 Cl 2 , washed with water and brine, dried (Na 2 SO 4 ), filtered and concentrated at reduced pressure to give an oil which was purified by flash chromatography (AcOEt/hexane 2 : 1), to yield 1.22 g (84%) of the amide 9a as a white solid, mp 140-141°C (isoPrOH N-(1-Benzenesulfonyl-3-ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylacetyl)morpholine (9a) General procedure A 2 M solution of Me 3 Al in hexane (1.30 ml, 2.57 mmol) was added to a mixture of morpholine (0.22 ml, 2.57 mmol) in dry CHCl 3 (10 ml). After stirring at room temperature under argon for 15 min, a solution of the compound 3 (0.49 g, 1.28 mmol) in CHCl 3 (10 ml) was added dropwise. The mixture was refluxed for 12 h, cooled and acidified with 10% HCl (5 ml), the organic layer was washed with water, dried (Na 2 SO 4 ) and concentrated to give a residue which was purified by column chromatography (AcOEt/hexane 2 : 1) to afford 0.47 g (85%) of the amide 9a as a white solid. N-[b b-(1-Benzenesulfonyl-3-ethyl-2-methyl-4-hydroxy-4,5,6,7-tetrahydro-5-indolyl)ethyl)]morpholine (10a) A 1 M solution of AlH 3 in THF (11.3 ml, 11.3 mmol, 5 eq) was added dropwise to a solution of amide 9a (1.0 g, 2.2 mmol) in anhydrous THF (25 ml), the mixture was stirred under Ar at room temperature for 12 h. After this time, the mixture was poured into 10% NaOH (35 ml) and extracted with CH 2 Cl 2 . The organic extracts were dried (Na 2 SO 4 ) and concentrated in vacuo. The residue was subjected to column chromatography (AcOEt) to give 0.78 g (80%) of the aminoalcohol 10a as a colourless oil. IR (film) N-[b b-(3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolyl)ethyl)]morpholine (12a) General Procedure A 15% solution of NaOH in ethanol (1.2 ml, 4.6 mmol, 2 eq) was added dropwise to a solution of the amine 11a (1.0, 2.3 mmol) in ethanol (50 ml). The mixture was refluxed for 12 h and then concentrated in vacuo. The residue was dissolved in CH 2 Cl 2 , washed with water, dried (Na 2 SO 4 ) and concentrated to give a grey solid which was purified by column chromatography (AcOEt) to afford 0.50 g (74%) of the amine 12a as a white solid, mp 127-128°C (hexane). IR (KBr) cm was then added to the mixture at 0°C and stirred for 1 h and then at room temperature for 16 h. After removal of the dicyclohexylurea formed by filtration, the DMF was distilled in vacuo, the resulting oil dissolved in ethyl acetate and the solution washed several times with 5% NaHCO 3 , and water, dried (Na 2 SO 4 ) and the solvent removed at reduced pressure. The oil residue was purified by column chromatography (AcOEt/hexane 2 : 1) to give 3.31 g (85%) of 8e as a foam solid. IR (KBr) cm 59 mol) and freshly prepared pyridinium tosylate (0.5 g) in anhydrous toluene (100 ml) was refluxed in a Dean-Stark apparatus for 200 h with azeotropic distillation of water. After cooling, the toluene solution was washed with 10% NaOH (2ϫ50 ml), water (2ϫ50 ml), dried and the solvent distilled in vacuo to give 2 g (50%) of a yellow foam solid which was used in the next step whithout further purification. IR (film) cm Ϫ1 : 2962 (C-H), 1639 (CϭO). (20 ml) was added dropwise to a stirred suspension of LiAlH 4 (0.3 g, 7.8 mmol) in anhydrous ether. Under vigorous stirring, the resulting suspension was heated under reflux for 2 h. After cooling in an ice bath, the reaction mixture was quenched by cautious addition of a saturated solution of sodium potassium tartrate. The white coarse precipitate formed was filtered off and thoroughly washed with ether. The combined filtrates were dried and the solvent distilled in vacuo. The crude bis ethylene ketal 14 (0.70 g, 70%) was dissolved in abs. MeOH and acidified with MeOH-HCl saturated. After 15-20 min on standing at room temperature, 20% HCl was added and the resulting solution heated under reflux with vigorous stirring for 2 h. After cooling, the solution was made alkaline with 10% NaOH and then extracted into ethyl acetate, the organic layer was dried and the solvent was removed in vacuo to give 0.45 g of a brown oil which was subjected to column chromatographic purification using AcOEt to elute 0.35 g (50%) of 15 as a colorless oil which decomposed after attempted ball to ball distillation. N-(3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydro-5-indolylethyl)-4-(p-fluorobenzoyl)piperidine (12e) Under an argon atmosphere, to a solution of sulfonamide 15 (0.24 g, 0.50 mmol) in anhydrous THF (0.4 ml) at Ϫ78°C was distilled about 6 ml of ammonia. Sodium (0.03 g, 3 at-g) was added until a blue coloration persisted for 25 min after which the reaction was quenched with ammonium chloride (0.30 g). Ammonia was allowed to evaporate and the resulting residue partitioned between water (2 ml) and CH 2 Cl 2 (10 ml). The water layer was washed with CH 2 Cl 2 and the combined organic layers, dried (Na 2 SO 4 ) and concentrated to give 140 mg (60%; 10% from 8e) of a yellow oil which was purified by flash chromatography (AcOEt as eluent) to give a colorless oil which slowly crystallized on standing, mp 168-170°C. N-(3-Ethyl-2-methyl-4,5,6,7-tetrahydro-5-indolylethyl)-4-( p-fluorobenzoyl)piperidine, Ethylene Ketal (16) The experimental procedure was similar to that described for 14 (vide supra) but using THF (70°C) instead ether. After chromatographic purification an amorphous solid (70%) was obtained from which a satisfactory elemental analysis could not be obtained.
N-(1-Benzenesulfonyl-3-ethyl-2-methyl-4,5,6,7-tetrahydro-5-indolylethyl)-4-(p-fluorobenzoyl)piperidine, Ethylene Ketal (17) Under an argon atmosphere, a 1 M solution of AlH 3 in THF (1.5 ml, 1.5 mmol, 5 eq) was added slowly by syringe to a solution of amide 13 (0.2 g, 0.31 mmol) in anhydrous THF (6 ml). The resulting mixture was stirred at room temperature for 15 h, after which the solution was made basic with 10% NaOH (35 ml) and extracted into CH 2 Cl 2 . The combined organic layers were washed with water, dried (Na 2 SO 4 ) and the solvent removed in vacuo. After chromatographic purification (silica gel, ethyl acetate) 17 was obtained as an amorphous solid foam (0.12 g, 70%) which was directly used in the next step. A sample was subjected to spectroscopic measurement. A sample of 17 (200 mg, 0.34 mmol) was dissolved in abs. MeOH (1.5 ml) and the solution acidified with MeOH-HCl saturated until pH 1-2. After 15-30 min of standing at room temperature, 20% HCl (20 ml) was added and the resulting solution heated at 60-65°C under vigorous stirring for 2 h. After cooling, the solution was made basic with 10% NaOH and then extracted into ethyl acetate which was washed with water, dried and the solvent distilled off. The residue was subjected to column chromatographic purification using AcOEt as eluent to give 0.11 g (55%) of 18 as a colorless oil from which crystalline oxalate and oxime were obtained. .38 mmol) in EtOH (1.5 ml) and pyridine (1.5 ml, 0.018 mol) was heated to 100°C for 2 h. Then, the solvent was removed in vacuo and H 2 O (1.5 ml) was added. The oxime crystallized on cooling to give a white solid of mp 213-214°C (iso-PrOH). MS m/z: 552 (Mϩ1, 87%), 410 (41%), 235 (100%), 188 (57%), 162 (27%), 96 (27%).
1,4-Dihydro-3,5-dimethoxybenzoic Acid (21) To a solution of 3,4,5-trimethoxybenzoic acid (8.0 g, 37 mmol) in methanol (50 ml) and liquid ammonia (180 ml) was added lithium (4.5 g) in small pieces. When the addition was complete, ammonium chloride (20 g) was added, and the ammonia was allowed to evaporate at room temperature. The residue was dissolved in icewater and the solution was acidified at 0°C with 2 M HCl to congo red. The solution was extracted with methylene chloride and the combined organic phases were washed with water, dried (Na 2 SO 4 ) and evaporated under reduced pressure giving 6.5 g (93%) of 21 as a white solid, mp 99-104°C (hexane).
1,4-Dihydro-3,5-dimethoxybenzyl Alcohol (22) A solution of 1,4-dihydro-3,5-dimethoxybenzoic acid 21 (3.45 g, 18.7 mmol) in dry ether (100 ml) was added to a suspension of LiAlH 4 (2.85 g, 75.1 mmol) in dry ether (150 ml). The reaction mixture was stirred for 18 h under argon atmosphere, and then water (4.2 ml), 2 M NaOH (4.2 ml) and water (18 ml) were added. White aluminium hydroxides were filtered off and the filtrate was dried (Na 2 SO 4 ) and the solvent was removed in vacuo to give 2.90 g (90%) of 22 as a colourless oil which crystallized on cooling, mp 41-43°C.
3-Ethyl-2-methyl-6-hydroxymethyl-4,5,6,7-tetrahydroindol-4-one (24) A solution of bis(enol ether) 22 (1.37 g, 8 mmol) in 70% aqueous acetic acid (25 ml) was refluxed for 15 min, then removed from the heating bath and Zn powder (1.16 g, 24 mol) was added in portions over 15 min with stirring. The mixture was heated to reflux and a solution of 2-isonitroso-3-pentanone (1.12 g, 9 mmol) in 70% aqueous acetic acid (10 ml) was added. The resulting mixture was refluxed for 4 h and then cooled to room temperature. The solvent was evaporated, and the residue was dissolved in water (30 ml) and extracted with CH 2 Cl 2 (3ϫ25 ml). The aqueous solution was evaporated and the residue was treated with CH 2 Cl 2 (50 ml), the zinc acetate was removed by filtration and the filtrate was dried (Na 2 SO 4 ). The combined organic extracts were concentrated to give 1.54 g of yellow solid which was purified by column chromatography (silica gel, AcOEt/hexane 2 : 1) to afford 0.60 g (30%, Rfϭ 0.40) of 3-ethyl-2-methyl-6-acetoxymethyl-4,5,6,7-tetrahydroindol-4-one (23) and 0.50 g (30%, Rfϭ0.07) of 3-ethyl-2-methyl-6-hydroxymethyl-4,5,6,7-tetrahydroindol-4-one (24 The acetyl derivative 23 (0.55 g, 2.2 mmol) was dissolved in ethanol (5 ml) and a 10% solution of KOH in ethanol (6.2 ml) was added. The mixture was refluxed for 12 h. Solvent was evaporated at reduced pressure and the residue dissolved in CH 2 Cl 2 and washed with water. The organic layer was dried (Na 2 SO 4 ), filtered and the solvent was evaporated in vacuo to give 0.58 g of a brown solid which was purified by column chromatography (silica gel, AcOEt/hexane 2 : 1) to afford 0.28 g (60%) of 24.
3-Ethyl-2-methyl-6-( p-tolylsulfonyl)oxymethyl-4,5,6,7-tetrahydroindol-4-one (25) p-Toluenesulfonyl chloride (3.3 g, 17.4 mmol) was added to a cooled solution of the alcohol 24 (1.8 g, 8.7 mmol) in dry pyridine (50 ml) and the mixture stirred at 0°C for 24 h. Ice water was then added to the reaction mixture, and the resultant solid was collected by filtration and washed with water to give 1.57 g (50%) of 25 as a white solid, mp 153-154°C (toluene 3-Ethyl-2-methyl-6-morpholinylmethyl-4,5,6,7-tetrahydroindol-4-one (26a). General procedure: A solution of the tosylate 25 (0.20 g, 0.55 mmol) and morpholine (0.10 g, 1.1 mmol) in 1-methyl-2-pyrrolidone (NMP, 6 ml) was stirred at 85°C for 16 h. The solvent was evaporated under reduced pressure and the residue was purified by chromatography on silica with ethyl acetate as eluant to give 0.11 g (75%) of 26a as white solid, mp 127-130°C.
3-Ethyl-2-methyl-6-piperazin- 
